HLN.L vs PRGO
HLN.L: A leading global consumer healthcare business managing a portfolio of world-class brands in pain relief, oral health, and wellness. PRGO: A struggling diversified consumer and prescription healthcare manufacturer navigating portfolio restructuring and strategic divestitures amid margin pressure and competitive headwinds.
Side-by-side fundamentals
| Metric | HLN.L | PRGO | Edge |
|---|---|---|---|
| Price as of 2026-08-05 close | £3.66 | $12.54 | |
| Market cap as of 2026-08-08 | n/a | $1.7B | |
| PEG as of 2026-08-08 | n/a | -0.00 | |
| Net margin as of 2026-08-08 | n/a | -43.5% | |
| Gross margin as of 2026-08-08 | n/a | +34.2% | |
| Operating margin as of 2026-08-08 | n/a | -36.9% | |
| ROE as of 2026-08-08 | n/a | -50.6% | |
| ROA as of 2026-08-08 | n/a | -19.8% | |
| Debt / equity as of 2026-08-08 | n/a | 1.45 | |
| Revenue growth (YoY) as of 2026-08-08 | n/a | -3.6% | |
| Revenue CAGR (3y) SEC XBRL | n/a | -1.5% | |
| Dividend yield as of 2026-08-08 | n/a | +9.3% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-08-08 | n/a | 0.67 | |
| 1-year return as of 2026-08-05 close | +4.5% | -46.9% | HLN.L higher |
Fundamentals: market data, as of 2026-08-08. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-05.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.